SPONSOR
L. Nicolas Gonzalez Castro, MD, PhD
Total Trials
1
Recruiting
1
Phases
Phase 2
L. Nicolas Gonzalez Castro, MD, PhD is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Glioblastoma, Recurrent Glioblastoma.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — L. Nicolas Gonzalez Castro, MD, PhD
How many clinical trials has L. Nicolas Gonzalez Castro, MD, PhD sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by L. Nicolas Gonzalez Castro, MD, PhD, of which 1 are actively recruiting participants. These trials cover conditions including Glioblastoma, Recurrent Glioblastoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does L. Nicolas Gonzalez Castro, MD, PhD research focus on?
L. Nicolas Gonzalez Castro, MD, PhD clinical trials span Glioblastoma, Recurrent Glioblastoma. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a L. Nicolas Gonzalez Castro, MD, PhD clinical trial?
To participate in a L. Nicolas Gonzalez Castro, MD, PhD trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all L. Nicolas Gonzalez Castro, MD, PhD trials with current recruitment status updated daily.
Clinical Trials by L. Nicolas Gonzalez Castro, MD, PhD
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology